Gabriel Wiedenhoever on Pharmaceutical Industry

Washington Healthcare Update - July 2024

This Week in Washington: House Ways and Means Committee marks up healthcare bills related to new technologies and coverage for weight loss drugs; CMS releases CY2025 Home Health and End-Stage Renal Disease PPS proposed rules;...more

7/2/2024 / Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Rep. Bucshon Introduces Latest 340B Legislation in the House

On May 28, 2024, Rep. Larry Bucshon (R-IN) introduced the “340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act.” This legislation is the latest bill introduced in the House attempting to clarify...more

6/11/2024 / Department of Health and Human Services (HHS) , Drug Pricing , Pharmaceutical Industry , Prescription Drugs , Section 340B

Washington Healthcare Update - February 2024 #2

This Week in Washington: Senate Finance Committee holds hearing on AI use in healthcare; CMS makes corrections to 2024 Hospital Outpatient Prospective Payment Rates; House passes ban on QALYs....more

2/13/2024 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicaid , OCR , Pharmaceutical Industry , Popular , Prescription Drugs , Proposed Rules , SAMHSA , Section 340B

Washington Healthcare Update - December 2023

This Week in Washington: House Energy and Commerce subcommittees look at role of AI and CDC respiratory disease preparedness; FDA releases final rule on prescription drug advertisements....more

12/5/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , OIG , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - November 2023 #3

This Week in Washington: House and Senate pass continuing resolution; House Energy and Commerce Health Subcommittee reports out 21 healthcare bills; Senate Finance Healthcare Subcommittee holds hearing on telehealth...more

11/21/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , Medicaid , Medicare , OIG , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Telehealth

Washington Healthcare Update - September 2023 #2

This Week in Washington: House stalls on defense spending bill, but begins negotiations among Republicans on appropriations; Senate was expected to move forward on three appropriations bills, but has now stalled; House to...more

9/19/2023 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Health Care Providers , OCR , Pharmaceutical Industry , Proposed Rules

Washington Healthcare Update - July 2023 #3

This Week in Washington: Senate Finance Committee reports out Modernizing and Ensuring PBM Accountability Act; House Ways and Means Committee reports out healthcare bills; Senate Appropriations Committee reports out FY 2024...more

8/1/2023 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Proposed Rules

Washington Healthcare Update - June 2023 #4

This Week in Washington: Senate Appropriations Committee meets to figure out top-line numbers; Majority Leader Schumer leads Senate in developing a policy response to artificial intelligence; and CMS proposes new Medicare...more

6/27/2023 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - June 2023 #3

This Week in Washington: FDA funding bill passes House Appropriations Committee, MedPAC and MacPAC release June 2023 report to Congress, RSC budget blueprint brings back premium support concept for Medicare...more

6/21/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - June 2023

This Week in Washington: Debt-ceiling agreement passes, House Energy and Commerce Committee reports out legislation on site-neutral Medicare payments for certain drugs...more

6/6/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , Medicaid , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Proposed Rules

Washington Healthcare Update - March 2023 #4

This Week in Washington: HHS Secretary appears before Senate Finance and Senate Appropriations Committees...more

3/28/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - March 2023 #2

Upcoming Hearings - March 15 - Senate Committee on Veterans’ Affairs Hearing: “Examining the Future Path of VA’s Electronic Health Record Modernization Program” - 3:30 p.m., Dirksen Senate Building 106...more

3/13/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Proposed Rules